Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jieshen Lotion is a Traditional Chinese Medicine (TCM) topical formulation developed by Shanxi Buchang Pharmaceutical for the treatment of gynecological inflammatory conditions. It is primarily indicated for vulvitis and various types of vaginitis, including trichomonal and candidal (fungal) infections, as well as associated symptoms like pruritus vulvae (itching) and abnormal vaginal discharge. The lotion is composed of multiple botanical extracts, typically including *Sophora flavescens* (Kushen), *Phellodendron amurense* (Huangbai), and *Cnidium monnieri* (Shechuangzi), which are traditionally recognized for their antimicrobial, anti-inflammatory, and antipruritic properties. It is intended for external use as a wash or topical application to alleviate local irritation and restore vaginal health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jieshen Lotion.